Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors. - Konig, H.; Holtz, M.; Modi, H.; Manley, P.; Holyoake, T. L.; Forman, S. J.; Bhatia, R. (Leukemia (08876924), 2008)